netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Recent Updates - Updated items

All Formulary Amendments

  Records 1 to 17 of 17


Details
UPD sitematrix Changed from 0 to
20/11/2023 12:44:03
(DavidS )
UPD FurtherInformation Changed from
  • 4mg & 10mg capsules
  • Approved with everolimus for previously treated advanced renal cell carcinoma in line with NICE
20/11/2023 12:44:03
(DavidS )
UPD Lenvatinib (Kisplyx®) updated formatting
20/11/2023 12:44:03
(DavidS )
UPD sitematrix Changed from 0 to
11/07/2023 17:30:14
(dmcdermott )
UPD FurtherInformation Changed from
11/07/2023 17:30:14
(dmcdermott )
UPD Lenvatinib (Kisplyx®) =
11/07/2023 17:30:14
(dmcdermott )
LDL Link Added : MHRA Drug Safety Update (July 2020): Systemically administered VEGF pathway inhibitors: risk of aneurysm and artery dissection : https://www.gov.uk/drug-safety-update/systemically-administered-vegf-pathway-inhibitors-risk-of-aneurysm-and-arte
11/07/2023 17:27:46
(dmcdermott )
LDL Link Added : NICE TA 551: Lenvatinib for untreated advanced hepatocellular carcinoma : https://www.nice.org.uk/guidance/ta551
24/01/2019 15:36:24
(DavidS )
UPD Lenvatinib (Kisplyx®) NICE TA551
24/01/2019 15:36:03
(DavidS )
LDL Link Added : NICE TA 535: Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodine : https://www.nice.org.uk/guidance/ta535
24/01/2019 15:02:55
(DavidS )
UPD Lenvatinib (Kisplyx®) NICE TA535
24/01/2019 15:02:21
(DavidS )
UPD Published from Draft Mode
09/05/2018 11:42:45
(LoweryM )
UPD Lenvatinib (Kisplyx®) updated
09/05/2018 11:42:02
(LoweryM )
UPD Lenvatinib (Kisplyx®) changed to protein kinase inhibitor
09/05/2018 11:25:30
(LoweryM )
LDL Link Added : NICE TA498: Lenvatinib with everolimus for previously treated advanced renal cell carcinoma : https://www.nice.org.uk/guidance/ta498
27/04/2018 12:14:07
(DavidS )
UPD Lenvatinib (Kisplyx®) NICE TA498. Approve at APC (APril 2018)
27/04/2018 12:13:37
(DavidS )
UPD Status Changed to | Hidden | Published
22/03/2017 15:10:44
(DavidS )

 

 
netFormulary